Pooled Safety Analysis of Relacorilant Plus Nab-paclitaxel in Patients With Platinum-resistant Ovarian Cancer Enrolled to ROSELLA and Study 552

Presented: European Society for Medical Oncology, 26 October 2026, Madrid, Spain

Presenter: Alexander B. Olawaiye, M.D.

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.